$125.69
-0.08-0.06%
At Close: -
$125.46
-0.23-0.18%
After Hours: 7:20 PM EDT
15 minutes delayed
Comments
Loading...
Merck & Co
MRKNYSE
Latest news for Merck & Co (NYSE:MRK) Stock
Merck & Co Stock (NYSE: MRK)
Categories: All
Thursday, July 18, 2024
Wednesday, July 17, 2024
Tuesday, July 16, 2024
Monday, July 15, 2024
Friday, July 12, 2024
Thursday, July 11, 2024
Tuesday, July 09, 2024
Sunday, July 07, 2024
Friday, July 05, 2024
Tuesday, July 02, 2024
Monday, July 01, 2024
Friday, June 28, 2024
Thursday, June 27, 2024
- Merck's Pneumonia Shot Recommended For Health...
- A Closer Look at Merck & Co's Options Market Dynamics
- CDC's ACIP Unanimously Votes To Add Merck And...
- Merck's Lung Cancer Candidate Faces FDA Rejection
- Merck & Company shares are trading lower afte...
- FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug
- Reported Earlier, FDA Issues Complete Respons...
Wednesday, June 26, 2024
Tuesday, June 25, 2024
Monday, June 24, 2024
Friday, June 21, 2024
Thursday, June 20, 2024
Tuesday, June 18, 2024
- Cracking The Code: Understanding Analyst Reviews For Merck & Co
- Competitor Analysis: Evaluating Merck & Co And Competitors In Pharmaceuticals Industry
- Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
- Cantor Fitzgerald Reiterates Overweight on Me...
- FDA Approves Merck's Pneumococcal Vaccine As First Shot Designed For Adults
- FDA Approves CAPVAXIVE, Sixth Product Using P...
- Merck shares are trading higher after the FDA...